Synthetic essentiality of TRAIL/TNFSF10 in VHL-deficient renal cell carcinoma
Xuechun Wang, Yujing Qin, Loan Duong, Minzhi Liang, Adrian Chao, Rossella Parrotta, Yaoyin Li, Paresh Kumar Purohit, Yihao Fang, Guoqiang Liu, Jianping He, Jiling Wen, Yan Liu, Yuting Zhang, Junling Zhao, , Éva Szegezdi
This study identifies TRAIL as a synthetic essentiality in VHL-deficient ccRCC, showing its regulation by HIF2 and its role in cell proliferation through the p38 MAPK pathway, suggesting a combination therapy strategy.
Proceedings of the National Academy of Sciences · Jul 1, 2026Peer-reviewedCancer Biology